Public Comments / Sponsor Resource
Comments provided on: March 8, 2023
Comments provided to: Food and Drug Administration re: Docket No. FDA-2020-N-0258
Comments provided on: March 8, 2023
Comments provided to: Food and Drug Administration re: Docket No. FDA-2020-N-0258
Comments provided on: Februrary 22, 2022
The MRCT Center submitted public comments to the National Institutes of Health (NIH) “Request for Information on Proposed Updates and Long-Term Considerations for the NIH Genomic Data Sharing Policy,” published in the Federal Register on November 30, 2021. The MRCT Center appreciates the NIH’s efforts to update its policy on Genomic Data Sharing (GDS) to maintain currency with evolving technology and understanding and commented on multiple issues, including de-identification and evolving concept of “identifiability,” data linkage, data management and sharing principles for NIH-supported resources, harmonization of GDS and NIH Policy for Data Management and Sharing (DMS) plans, and the types of research covered by the GDS policy. In addition, the MRCT Center proposed that the NIH consider several additional issues in its revision including withdrawal of consent, third party risks, harmonization with other federal and international agencies, the increased likelihood of re-identification with future technology advances, sanctions for misuse of data, public education, and the effectiveness and impact of the GDS policy.
Comments provided on: May 31, 2022
Comments provided to: U.S. Food and Drug Administration
Comments provided on: August 22, 2022
Comments provided to: Ministry of Health and Family Welfare, New Delhi, India
Released on: October 2, 2022
Published in: U.S. Department of Health and Human Services, Office for Civil Rights
Comments provided on: August 5, 2013
Comments provided to: Food and Drug Administration
Comments provided on: September 30, 2013
Comments provided to: European Medicines Agency
Comments provided on: September 11, 2014
Presented at: Food and Drug Administration
Comments provided on: January 7, 2020
Comments provided to: National Institutes of Health, Bethesda, Maryland